1. Home
  2. SEPN vs OMI Comparison

SEPN vs OMI Comparison

Compare SEPN & OMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • OMI
  • Stock Information
  • Founded
  • SEPN 2022
  • OMI 1882
  • Country
  • SEPN United States
  • OMI United States
  • Employees
  • SEPN N/A
  • OMI N/A
  • Industry
  • SEPN
  • OMI Medical Specialities
  • Sector
  • SEPN
  • OMI Health Care
  • Exchange
  • SEPN NYSE
  • OMI Nasdaq
  • Market Cap
  • SEPN 1.0B
  • OMI 909.7M
  • IPO Year
  • SEPN 2024
  • OMI N/A
  • Fundamental
  • Price
  • SEPN $22.53
  • OMI $12.25
  • Analyst Decision
  • SEPN
  • OMI Buy
  • Analyst Count
  • SEPN 0
  • OMI 6
  • Target Price
  • SEPN N/A
  • OMI $19.58
  • AVG Volume (30 Days)
  • SEPN 399.2K
  • OMI 902.0K
  • Earning Date
  • SEPN 11-26-2024
  • OMI 11-04-2024
  • Dividend Yield
  • SEPN N/A
  • OMI N/A
  • EPS Growth
  • SEPN N/A
  • OMI N/A
  • EPS
  • SEPN N/A
  • OMI N/A
  • Revenue
  • SEPN $838,000.00
  • OMI $10,660,960,000.00
  • Revenue This Year
  • SEPN N/A
  • OMI $4.87
  • Revenue Next Year
  • SEPN N/A
  • OMI $4.01
  • P/E Ratio
  • SEPN N/A
  • OMI N/A
  • Revenue Growth
  • SEPN N/A
  • OMI 4.22
  • 52 Week Low
  • SEPN $18.62
  • OMI $11.42
  • 52 Week High
  • SEPN $26.34
  • OMI $28.35
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • OMI 41.61
  • Support Level
  • SEPN N/A
  • OMI $11.98
  • Resistance Level
  • SEPN N/A
  • OMI $13.56
  • Average True Range (ATR)
  • SEPN 0.00
  • OMI 0.71
  • MACD
  • SEPN 0.00
  • OMI -0.01
  • Stochastic Oscillator
  • SEPN 0.00
  • OMI 35.78

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.

About OMI Owens & Minor Inc.

Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.

Share on Social Networks: